UnitedHealth Group Incorporated (UNH)
NYSE: UNH · IEX Real-Time Price · USD
487.30
+1.12 (0.23%)
At close: Apr 24, 2024, 4:00 PM
486.73
-0.57 (-0.12%)
Pre-market: Apr 25, 2024, 4:43 AM EDT
UnitedHealth Group Market Cap
UnitedHealth Group has a market cap or net worth of $449.26 billion as of April 24, 2024. Its market cap has decreased by -4.70% in one year.
Market Cap
449.26B
Enterprise Value
478.41B
1-Year Change
-4.70%
Ranking
Category
Stock Price
$487.30
Market Cap Chart
Since December 1, 1998, UnitedHealth Group's market cap has increased from $8.37B to $449.26B, an increase of 5,268.38%. That is a compound annual growth rate of 16.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 448.23B | -1.03% |
Apr 22, 2024 | 452.88B | -1.98% |
Apr 19, 2024 | 462.01B | 1.61% |
Apr 18, 2024 | 454.68B | 2.96% |
Apr 17, 2024 | 441.60B | 2.15% |
Apr 16, 2024 | 432.29B | 5.22% |
Apr 15, 2024 | 410.84B | 1.46% |
Apr 12, 2024 | 404.91B | -0.57% |
Apr 11, 2024 | 407.24B | -1.85% |
Apr 10, 2024 | 414.92B | -2.10% |
Apr 9, 2024 | 423.83B | 0.82% |
Apr 8, 2024 | 420.40B | 0.06% |
Apr 5, 2024 | 420.16B | 0.08% |
Apr 4, 2024 | 419.83B | -0.95% |
Apr 3, 2024 | 423.85B | 0.35% |
Apr 2, 2024 | 422.37B | -6.44% |
Apr 1, 2024 | 451.47B | -1.01% |
Mar 28, 2024 | 456.08B | 0.32% |
Mar 27, 2024 | 454.61B | 0.16% |
Mar 26, 2024 | 453.88B | 1.32% |
Mar 25, 2024 | 447.95B | -0.85% |
Mar 22, 2024 | 451.81B | -0.33% |
Mar 21, 2024 | 453.31B | -0.51% |
Mar 20, 2024 | 455.65B | 0.18% |
Mar 19, 2024 | 454.81B | 1.29% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 695.32B |
Novo Nordisk | 564.00B |
Johnson & Johnson | 359.35B |
Merck & Co. | 321.49B |
AbbVie | 297.27B |
AstraZeneca | 217.39B |
Thermo Fisher | 209.32B |
Novartis AG | 186.10B |